BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin, KS St. Gallen, Switzerland *Senior Laboratory Technician Core Lab, **Deputy Head of Department Core Lab/FAMH Candidate Clinical Chemistry, Centre for Laboratory Medicine, Frohbergstrasse
Continue Reading
Author: Collin Shaw
BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 A Report of A. Suter* and Dr. C. Fuhrer** from SYNLAB *BMA HF/ Fachleiterin, **Head of Core Lab, FAMH Clinical Chemistry, NF hematology, microbiology and immunology; SYNLAB Suisse SA, Alpenquai 14, 6002 Lucerne, Switzerland
Continue Reading
View a compilation of twelve user testimonials from UK, Ireland, Switzerland and France that have been published so far for the BÜHLMANN fCAL® turbo. Find valuable highlights, perspectives, advice and details about the successful applications of this automated calprotectin assay from each laboratory. Read Testimonials
Continue Reading
BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 80726 Abstract Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important
Continue Reading
BUHLMANN Diagnostic Corp (BDC), Amherst, NH is proud to announce they have entered into a distribution agreement with Meridian Bioscience, Inc., Cincinnati, Ohio to market the FDA-cleared BÜHLMANN fCAL® ELISA for the quantitative measurement of fecal calprotectin in human stool. The BÜHLMANN fCAL® ELISA aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s
Continue Reading
BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 Unilabs Portugal, a private European lab chain, made a comprehensive evaluation of different Calprotectin assays on the market and found many discrepancies with assays from other suppliers. Finally, they chose the BÜHLMANN fCAL® turbo simply because it
Continue Reading
BÜHLMANN fCAL® turbo BÜHLMANN fCAL® turbo (K190784): FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. CPT Code: Calprotectin – 83993 fecal Calprotectin (fCAL)- An FDA Cleared Gastrointestinal Test to Distinguish IBD from IBS Calprotectin is a highly-sensitive clinical biomarker that
Continue Reading
In this "Summer Edition" we are pleased to announce the FDA 510 (k) clearance of the BÜHLMANN fCAL® ELISA. We make mention of upcoming meetings where you can find us such as American Association of Clinical Chemistry (AACC) and the Association of Medical Laboratory Immunologists (AMLI) annual meetings. Additionally, we share the exciting happenings pertaining to
Continue Reading
We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Anti-MAG Autoantibodies ELISA This assay is intended for the quantitative determination of human IgM-auto-antibodies directed against Myelin Associated Glycoprotein (MAG) in serum. Health Canada License: 89118 US: Research Use Only. Not
Continue Reading
BÜHLMANN fCAL® ELISA, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, June 12, 2018: BÜHLMANN Laboratories AG, is proud to announce it has received United States Food and
Continue Reading
